A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinsons disease (the ADAGIO study): rationale, design, and baseline characteristics
And so we use the technology to literally, instead of working with medications, we start working with glutathione
J Toxicol Sci 33:389403
Stack 2: gut-brain healing (BPC-157 + KPV) This stack targets mood disorders through the gut-brain axis, making it particularly relevant for individuals whose depression or anxiety co-occurs with gastrointestinal symptoms, food sensitivities, or known inflammatory conditions
Throughout the day, the body produces unstable molecules called free radicals as a byproduct of normal metabolism, exposure to environmental pollutants, and stress
Key steps to ensure success include: Comprehensive lab testing to assess metabolic health and hormone levels